Ear seeds and allergy pills: a new combo for hives?
NCT ID NCT07575464
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding ear acupressure (using tiny seed patches on specific ear points) to a standard antihistamine (Loratadine) can better reduce hives symptoms and improve quality of life compared to a sham ear treatment. Sixty-six adults with Wind-Heat type urticaria will be randomly assigned to receive either real or fake ear acupressure for 4 weeks, while all take the same daily antihistamine. The main goal is to see if the real acupressure leads to a greater drop in itch and wheal scores.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Loratadine 10mg (antihistamine) plus auricular acupressure with Vaccaria seed patches
- What this could lead to
- If it works, this could offer a safe, low-cost add-on therapy to ease hives symptoms and improve quality of life.
- What could go wrong
- This is a small, early-stage trial with only 66 participants. The sham control may not fully blind participants, and results may not apply to other types of urticaria.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 66 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed with urticaria according to the international EAACI/GA²LEN/EuroGuiDerm/APAAACI 2022 guidelines. * Presenting typical clinical symptoms of urticaria. * Experiencing persistent itching and wheals, with an Urticaria Activity Score (UAS) indicating an itching and discomfort level of ≥ 1. * Diagnosed with the Wind-Heat syndrome according to Traditional Medicine criteria by a certified practitioner. Diagnosis requires the presence of main symptoms (persistent itchy rash, intense itching, bright red wheals) and at least 2 secondary symptoms (restlessness, feverish sensation, aversion to heat, sore throat, symptoms worsening with heat, thin yellow tongue coating, floating rapid pulse). * Voluntarily agrees to participate and signs the informed consent form. Exclusion Criteria: * Having contraindications to auricular acupressure according to the Ministry of Health, including severe physical exhaustion or immunodeficiency. * Having skin infections, inflammation, or ulceration at the auricular acupoint areas. * Experiencing acute pain suspected to be of surgical origin or in an emergency condition. * Pregnant women. * Use of stimulants (alcohol, beer, coffee, tobacco) within 24 hours prior to the study intervention. * Severe cognitive impairment or inability to understand the study protocol. * History of allergy or hypersensitivity to second-generation H1 antihistamines. * Currently participating in another interventional clinical study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Auricular acupressure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Department of Obstetrics, Le Van Thinh Hospital
Ho Chi Minh City, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test revolution: pinpointing the cause of swelling attacks
- Can a smartphone app ease the misery of eczema, psoriasis, and hives?
- AI tool aims to cut allergy misdiagnosis in primary care
- New tablet shows promise for chronic hives in small study
- New gel promises Ultra-Fast itch relief in seconds
- Smartphone AI could help doctors monitor skin disease remotely